WordNet

a contraceptive in the form of a pill containing estrogen and progestin to inhibit ovulation and so prevent conception (同)birth_control_pill, contraceptive pill, oral_contraceptive_pill, oral_contraceptive, anovulatory drug, anovulant
a dose of medicine in the form of a small pellet (同)lozenge, tablet, tab
something that resembles a tablet of medicine in shape or size
a unpleasant or tiresome person
something unpleasant or offensive that must be tolerated or endured; "his competitors success was a bitter pill to take"
restriction imposed by the government on documents or weapons that are available only to certain authorized people
a group of people or things arranged by class or category (同)categorization, categorisation
the basic cognitive process of arranging into classes or categories (同)categorization, categorisation, sorting
lying away from the median and sagittal plane of a body; "lateral lemniscus"
situated at or extending to the side; "the lateral branches of a tree"; "shot out sidelong boughs"- Tennyson (同)sidelong
comparative of the adverb `late; "he stayed later than you did"
coming at a subsequent time or stage; "without ulterior argument"; "the mood posterior to" (同)ulterior, posterior
a prominent supporter; "he is a pillar of the community" (同)mainstay
a fundamental principle or practice; "science eroded the pillars of superstition"

PrepTutorEJDIC

『丸薬』;《the pill》《話》ピル(経口避妊薬) / (耐えなければならない)不快なこと,苦しいこと / 《通例単数形で》《俗》いやなやつ
〈U〉〈C〉分類[作業];分類法;分類結果 / 〈U〉(生物学上の)分類
横の,側面の;横からの / (音声が)側音の / 側面,(道路の)側溝(そっこう) / 側音(英語の[1]など)
《補語にのみ用いて》(人などが)(…するのが)『もっと遅い』《+『in』+『名』(do『ing』)》 / (時刻・時期が)『もっと遅い』,もっと後の / 後で,のちほど / (lateの比較級)(定刻・予定時間・他の人(物))より遅れて,遅く
『柱』;『記念柱』 / 柱(状の…)《+『of』+『名』》 / (…の)柱となる人,大黒柱《+『of』+『名』》

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 筋萎縮性側索硬化症およびその他の運動ニューロン疾患の臨床的特徴 clinical features of amyotrophic lateral sclerosis and other forms of motor neuron disease
2. 家族性筋萎縮性側索硬化症 familial amyotrophic lateral sclerosis
3. 筋萎縮性側索硬化症およびその他の運動ニューロン疾患の診断 diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease
4. 小児および思春期における頸椎損傷の評価 evaluation of cervical spine injuries in children and adolescents
5. Approach to the athlete or active adult with knee pain

English Journal

Role of leptin in Legg-Calvé-Perthes disease.

Lee JH1, Zhou L, Kwon KS, Lee D, Park BH, Kim JR.Author information 1Department of Preventive Medicine, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju, Jeonbuk, 561-756, Republic of Korea.AbstractObesity is considered a clinical risk sign for Legg-Calvé-Perthes disease (LCPD). Leptin is primarily secreted by adipocytes, and it regulates adipose tissue mass and body weight. Furthermore, obesity is clearly associated with increased leptin levels. We investigated the roles of leptin and the soluble leptin receptor (sOB-R) in LCPD. This matched case-control study included 38 male and 3 female patients with LCPD, and an equal number of age-(range was 4-12) and sex-matched control patients with healthy fractures. Serum leptin and sOB-R levels were quantified with ELISA. The free leptin index (FLI) was defined as the ratio of leptin to sOB-R levels. Serum leptin levels, sOB-R, and FLI were compared between groups. The relationship between leptin, disease severity, and treatment outcomes were analyzed in the LCPD group. There were no significant differences between groups in terms of age, sex, and body mass index (BMI) percentile. Mean leptin levels (p = 0.042), sOB-R levels (p = 0.003), and FLI (p = 0.013) differed significantly between groups. In the LCPD group, the serum leptin levels, sOB-R levels, and FLI differed significantly between the lateral pillar and Stulberg classification groups (p < 0.05). Also, the leptin levels and FLI increased significantly according to the lateral pillar and Stulberg classifications even after adjusting for age and BMI percentile (p < 0.05). Circulating leptin and FLI were significantly higher in the LCPD group. Furthermore, leptin, disease severity, and treatment outcomes were associated. This correlation suggests that leptin might play an important role in LCPD pathogenesis.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society.J Orthop Res.2013 Oct;31(10):1605-10. doi: 10.1002/jor.22415. Epub 2013 Jul 5.
Obesity is considered a clinical risk sign for Legg-Calvé-Perthes disease (LCPD). Leptin is primarily secreted by adipocytes, and it regulates adipose tissue mass and body weight. Furthermore, obesity is clearly associated with increased leptin levels. We investigated the roles of leptin and the so
PMID 23832827

Can residual leg shortening be predicted in patients with Legg-Calvé-Perthes' disease?

Park KW1, Jang KS, Song HR.Author information 1Institute for Rare Diseases and Department of Orthopaedic Surgery, Korea University Medical Center, Guro Hospital, 80, Guro-Dong, Guro-Gu, Seoul, 152-703, Korea.AbstractBACKGROUND: Although Legg-Calvé-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified.
Clinical orthopaedics and related research.Clin Orthop Relat Res.2013 Aug;471(8):2570-7. doi: 10.1007/s11999-013-3009-4. Epub 2013 Apr 25.
BACKGROUND: Although Legg-Calvé-Perthes' disease (LCPD) is frequently associated with varying degrees of femoral head deformity and leg length discrepancy (LLD), no factors that predict residual shortening have been clearly identified.QUESTIONS/PURPOSES: We attempted to determine whether (1) the ex
PMID 23616268

Classifications in brief: the Herring lateral pillar classification for Legg-Calvé-Perthes disease.

Kollitz KM1, Gee AO.
Clinical orthopaedics and related research.Clin Orthop Relat Res.2013 Jul;471(7):2068-72. doi: 10.1007/s11999-013-2992-9. Epub 2013 Apr 20.
PMID 23604650